WHO recommends Merck COVID-19 pill for non-severe, at-risk patients
- The pill, called molnupiravir and developed by US pharmaceutical Merck, is taken as soon as possible after Covid-19 symptoms develop and then for the following five days
Merck & Co.
Arab News
